The occurrence of high rates of somatic mutations in cancer is thought to match increased frequency of neo-epitope formation and tumor immunogenicity. to determine an increased incident of neo-epitope development and, therefore, tumor immunogenicity [5]. Consequently, classification of malignancy patients according with their somatic mutational position could be becoming proposed like a predictive biomarker of… Continue reading The occurrence of high rates of somatic mutations in cancer is